Sarepta Therapeutics
A biopharmaceutical company.
Based in MA
🤖
AI Overview
With $800K in lobbying spend across 18 quarterly filings, Sarepta Therapeutics is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2018 to 2022.
$800K
Total Spend
5
Years Active
1
Firms Hired
9
Lobbyists Deployed
3
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $200K |
| 2019 | $200K |
| 2020 | $200K |
| 2021 | $200K |
| 2022 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid, Budget/Appropriations
- •Issues related to medicare and Medicaid reimbursement, issues related to rare diseases.
- •Issues related to Medicare and Medicaid reimbursement; Issues related to rare diseases.
- •Issues related to Medicare and Medicaid reimbursement; Issues related to rare disease.
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
The 22,000% ROI
When lobbying spending yields outsized returns.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.